Table: Taiko Pharmaceutical -2024 parent results
Feb 13 (Reuters)-
Taiko Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.55 5.43
(+2.1 pct) (+16.9 pct)
Operating 501 mln loss 1.04
Recurring 947 mln loss 1.33
Net 1.17 loss 3.72
EPS 23.34 yen loss 78.63 yen
Ann Div NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T